Skip to main content

Peer Review reports

From: Clinical insight among persons with schizophrenia spectrum disorders treated with amisulpride, aripiprazole or olanzapine: a semi-randomised trial

Original Submission
17 Jan 2023 Submitted Original manuscript
10 Feb 2023 Reviewed Reviewer Report
25 Feb 2023 Reviewed Reviewer Report
20 Mar 2023 Author responded Author comments - Lena Antonsen Stabell
Resubmission - Version 2
20 Mar 2023 Submitted Manuscript version 2
22 Mar 2023 Author responded Author comments - Lena Antonsen Stabell
Resubmission - Version 3
22 Mar 2023 Submitted Manuscript version 3
3 Apr 2023 Reviewed Reviewer Report
5 Apr 2023 Reviewed Reviewer Report
28 Apr 2023 Author responded Author comments - Lena Antonsen Stabell
Resubmission - Version 4
28 Apr 2023 Submitted Manuscript version 4
2 May 2023 Author responded Author comments - Lena Antonsen Stabell
Resubmission - Version 5
2 May 2023 Submitted Manuscript version 5
20 May 2023 Reviewed Reviewer Report
24 May 2023 Reviewed Reviewer Report
18 Jun 2023 Author responded Author comments - Lena Antonsen Stabell
Resubmission - Version 6
18 Jun 2023 Submitted Manuscript version 6
Publishing
22 Jun 2023 Editorially accepted
29 Jun 2023 Article published 10.1186/s12888-023-04981-9

You can find further information about peer review here.

Back to article page